Utah Medical Products, Inc. Stock
Equities
UTMD
US9174881089
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
69.72 USD | -1.04% | +1.43% | -17.22% |
Financials (USD)
Sales 2022 | 52.28M | Sales 2023 | 50.22M | Capitalization | 306M |
---|---|---|---|---|---|
Net income 2022 | 16M | Net income 2023 | 16M | EV / Sales 2022 | 5.55 x |
Net cash position 2022 | 74.66M | Net cash position 2023 | 92.53M | EV / Sales 2023 | 4.24 x |
P/E ratio 2022 |
22.2
x | P/E ratio 2023 |
18.4
x | Employees | 180 |
Yield 2022 |
1.16% | Yield 2023 |
1.41% | Free-Float | 93.37% |
1 day | -1.04% | ||
1 week | +1.43% | ||
Current month | +5.32% | ||
1 month | +3.70% | ||
3 months | -3.70% | ||
6 months | -17.00% | ||
Current year | -17.22% |
Managers | Title | Age | Since |
---|---|---|---|
Kevin Cornwell
CEO | Chief Executive Officer | 77 | 92-11-30 |
Brian Koopman
DFI | Director of Finance/CFO | 54 | 05-12-31 |
Paul Richins
BRD | Director/Board Member | 63 | 89-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kevin Cornwell
CEO | Chief Executive Officer | 77 | 92-11-30 |
Ernst Hoyer
BRD | Director/Board Member | 86 | 95-12-31 |
Paul Richins
BRD | Director/Board Member | 63 | 89-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.27% | 25 M€ | -1.43% | - | |
0.00% | 1,487 M€ | +9.17% | - | |
0.00% | 9 M€ | +11.05% | - | |
0.00% | 17 M€ | +5.25% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 69.72 | -1.04% | 8,828 |
24-05-16 | 70.45 | +1.75% | 13,732 |
24-05-15 | 69.24 | +1.11% | 31,026 |
24-05-14 | 68.48 | +0.01% | 16,862 |
24-05-13 | 68.47 | -0.39% | 18,121 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-17.22% | 246M | |
-5.43% | 181B | |
+4.30% | 114B | |
-3.09% | 68.29B | |
+5.86% | 52.24B | |
+8.15% | 44.3B | |
+7.52% | 42.73B | |
+25.54% | 32.52B | |
+17.85% | 26.02B | |
+1.00% | 25.91B |
- Stock Market
- Equities
- UTMD Stock